Assessment of cardiac risk before non-cardiac surgery: Brain natriuretic peptide in 1590 patients

Heart

Volumn 92, Issue 11, 2006, Pages 1645-1650

  Dernellis, John ^a,b   Panaretou, M ^b  

^a Vostanion Hospital ^*  (Greece)

^b Vostanion Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIVARIATE ANALYSIS; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; RISK ASSESSMENT; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 33750353355     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.085530     Document Type: Article

References (25)

1. Goldman L. Cardiac risks and complications of noncardiac surgery. Ann Intern Med 1983;98:504-13.
2. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990;72:153-84.
3. Kazmers A, Cerqueira MD, Zierler RE. The role of preoperative radionuclide ejection fraction in direct abdominal aortic aneurysm repair. J Vasc Surg 1988;8:128-36.
4. Gerson MC, Hurst JM, Hertzberg VS, et al. Cardiac prognosis in noncardiac geriatric surgery. Ann Intern Med 1985;103:832-7.
5. Halm EA, Browner WS, Tubau JF, et al. Echocardiography for assessing cardiac risk in patients having noncardiac surgery. Study of Perioperative Ischemia Research group. Ann Intern Med 1996;125:433-41.
6. Freeman WK, Gibbons RJ, Shub C. Preoperative assessment of cardiac patients undergoing noncardiac surgical procedures. Mayo Clin Proc 1989;64:1105-17.
7. Gage AA, Bhayana JN, Balu V, et al. Assessment of cardiac risk in surgical patients. Arch Surg 1977;112:1488-92.
8. Stevenson LW. The limited availability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989;261:884-8.
9. Gottdiener JS, McClelland RL, Marshall R, et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The cardiovascular health study. Ann Intern Med 2002;137:631-9.
10. McCullough PA. B-type natriuretic peptides: a diagnostic breakthrough in heart failure. Minerva Cardioangiol 2003;51:121-9.
11. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297:845-50.
12. Dernellis JM, Panaretou MP. Effects of digoxin on left atrial function in heart failure. Heart 2003;89:1308-15.
13. National Committee for Clinical Laboratory Standards. Evaluation of precision performance of clinical chemistry devices: approved guideline, NCCLS Document EP5-A. Wayne, Pennsylvania: NCCLS, 1999.
14. National Committee for Clinical Laboratory Standards. Method comparison and bias estimation using patient samples: approved guideline, NCCLS Document EP9-A. Wayne, PA: NCCLS, 1995.
15. Yeh HM, Lau HP, Lin JM, et al. Preoperative plasma N-terminal pro-brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non-cardiac surgery. Br J Surg 2005;92:1041-5.
16. Cohen MC, Eagle KA. The role of the cardiology consultant. In: Topol EJ, eds. Comprehensive cardiovascular medicine. Philadelphia: Lippincott-Raven, 1147-71).
17. Brown KA, Rowen M. Extent of jeopardized viable myocardium determined by myocardial perfusion imaging best predicts perioperative cardiac events in patients undergoing noncardiac surgery. J Am Coll Cardiol 1993;21:325-30.
18. Tang WHW, Philip K, Hazen SL, et al. Comparative sensitivities between different plasma B-type natriuretic peptide assays in patients with minimally symptomatic heart failure. Clin Cornerstone 2005;7(suppl 1):S18-S24.
19. Tang WH, Girod JP, Lee MJ, et al. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation 2003;108:2964-6.
20. Mueller T, Gegenhuber A, Poetz W, et al. Preliminary evaluation of the AxSYM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA Centaur BNP assay. Clin Chem 2004;50:1104-6.
21. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002;39:542-53.
22. Mangano DT, Goldman L. Preoperative assessment of patients with known or suspected coronary disease. N Engl J Med 1995;333:1750-6.
23. Heeschen C, Hamm CW, Mitrovic V, et al. N-terminal Pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004;110:3206-12.
24. Bibbins-Domingo K, Ansari M, Schiller NB, et al. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul Study. Circulation 2003;108:2987-92.
25. Hama N, Itoh H, Shirakami G, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 1995;92:1558-64.